Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Inspire Medical Systems ( (INSP) ) just unveiled an announcement.
Inspire Medical Systems reported its financial results for the third quarter of 2025, showing a 10% increase in revenue to $224.5 million compared to the previous year. The company achieved a gross margin of 85.8% and a net income of $9.9 million. The Inspire V system, which offers enhanced performance and reduced surgical procedure time, has received positive feedback from clinicians, with over 75% of centers ready to transition to this new system. Inspire reaffirmed its full-year revenue guidance of $900 to $910 million and increased its diluted net income per share guidance to $0.90 to $1.00. The company completed a $50 million share repurchase and presented clinical evidence of the Inspire V system’s efficacy at industry meetings.
The most recent analyst rating on (INSP) stock is a Hold with a $77.00 price target. To see the full list of analyst forecasts on Inspire Medical Systems stock, see the INSP Stock Forecast page.
Spark’s Take on INSP Stock
According to Spark, TipRanks’ AI Analyst, INSP is a Neutral.
Inspire Medical Systems’ overall stock score is primarily influenced by its strong financial performance, despite challenges in profitability and cash flow conversion. Technical analysis indicates bearish momentum, while valuation metrics suggest the stock is overvalued. The mixed sentiment from the earnings call, with significant lowlights, further impacts the score.
To see Spark’s full report on INSP stock, click here.
More about Inspire Medical Systems
Inspire Medical Systems is a medical technology company specializing in the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Their proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Average Trading Volume: 1,252,498
Technical Sentiment Signal: Sell
Current Market Cap: $2.13B
Find detailed analytics on INSP stock on TipRanks’ Stock Analysis page.